article · Trials

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial

Kyla Murphy
Rachel Wake
Marise Bremer
Vu Quoc Dat
Merika Tsitsi
Tim Harrison
Shabbar Jaffar
Douglas Wilson
Michelle Eriksson
Angela Loyse
Jack Adams
Jeremy Nel
Síle F. Molloy
Ebrahim Variava
Nowshad Alam
Sokoine Kivuyo
Colin Menezes
Thuy Le
David S. Lawrence
John Black
Duolao Wang
Denise Kyazze
Joseph N. Jarvis
Sayoki Mfinanga
Mahomed-Yunus Moosa
Charlotte Schutz
Graeme Meintjes
John Black
Rachel M. Wake
Merika Tsitsi
Douglas P. Wilson
Thomas S. Harrison
Graeme Meintjes
Michelle Eriksson
Mahomed-Yunus Moosa
Marise Bremer
Jeremy S. Nel
Sokoine Kivuyo
Joseph N. Jarvis
Sayoki Mfinanga
Denise Kyazze
Angela Loyse
Jack Adams
Duolao Wang
Nowshad Alam
Colin Menezes
David S. Lawrence
Ebrahim Variava
Nelesh P. Govender
N. Govender

2026Open accessUniversity of KwaZulu-Natal

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s13063-026-09520-x

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial

In plain language

Abstract

Research topics

Sustainable Development Goals

Read the original research

Discuss this research